The KDIGO CKD 2024 Guideline Draft
It’s time for another NephJC draft! This time, the crew breaks down the 2024 KDIGO chronic kidney disease (CKD) guideline. This was the first update since 2012.
Genetic Classification Model Differentiates MDS Stem, Progenitor Cells from Healthy Bone Marrow
FDA Grants Breakthrough Therapy Designation to Sacituzumab Govitecan for Second-Line Treatment of ES-SCLC
Genetic Study Uncovers Potential Therapy-Actionable Transcription Factors in MDS